Search results
Showing 8221 to 8235 of 8887 results
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Discontinued Reference number: GID-TA10764
In development Reference number: GID-TA11511 Expected publication date: TBC
Pembrolizumab for adjuvant treatment of hepatocellular carcinoma [ID3994]
In development Reference number: GID-TA10895 Expected publication date: 29 October 2026
Discontinued Reference number: GID-TA10663
Discontinued Reference number: GID-TA10689
Discontinued Reference number: GID-TA10836
Nivolumab for adjuvant treatment of resected non-small-cell lung cancer [ID4053]
In development Reference number: GID-TA10935 Expected publication date: TBC
Ofatumumab for the maintenance treatment of relapsed chronic lymphocytic leukaemia [ID732]
Discontinued Reference number: GID-TAG482
Discontinued Reference number: GID-TA10933
Discontinued Reference number: GID-TA10841
Discontinued Reference number: GID-TA10783
Discontinued Reference number: GID-TA10926
Digital technologies to support smoking cessation in secondary care patients: early value assessment
In development Reference number: GID-HTE10061 Expected publication date: TBC
In development Reference number: GID-TA11214 Expected publication date: TBC